Code | 0417E |
MA number | EU/1/22/1631/001 |
Product Form: | dis inf 1-4x4,6 ml (liek.inj.COC) |
MA Status: | E - Valid centralised marketing authorisation |
Type of procedure: | EU |
MAH, country: | Bristol-Myers Squibb Pharma EEIG , Ireland |
Shelf life: | 13 |
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 04.04.2022 |
Validity: | 04.04.2027 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | No |
Data update: | 14.04.2022 |